Following a court judgment in its favor last year, Merck & Co. is formally bidding adieu to more than 1,000 lawsuits alleging its shingles vaccine Zostavax caused patients to develop the disease.

After a drawn-out litigation process, Merck & Co. seems to have finally washed its hands of more than a thousand lawsuits tied to its shingles vaccine Zostavax. Late last week, the U.S. Court of ...

New research shows that shingles vaccination may not just reduce dementia risk but slow disease progression as well.

Consumer Reports has no financial relationship with advertisers on this site. Today, the Centers for Disease Control and Prevention made its formal recommendations for the use of Shingrix—a new ...

There’s a new shingles vaccine and experts say you should get it if you’re over 50 — even if you’ve already been vaccinated. The new vaccine, called Shingrix, works far better to prevent the extremely ...

The federal government's Advisory Committee on Immunization Practices (ACIP) voted 8 to 7 today to recommend a new recombinant and adjuvanted herpes zoster vaccine (Shingrix, GlaxoSmithKline) over a ...

Prospects for GlaxoSmithKline’s new shingle vaccine Shingrix have been raised after US advisors recommended that it should be used instead of rival Zostavax from Merck & Co. The Centres for Disease ...

Varicella zoster virus (VZV) is the virus that causes chicken pox, usually a relatively minor childhood illness. Unlike other viruses that are cleared from our bodies after infection, VZV stays in our ...

The litigation over the Zostavax shingles vaccine is facing another setback after a federal judge tossed the plaintiff's only causation expert from an upcoming bellwether trial. On Oct. 4, U.S.